A Study of LY4515100 in Participants With Pain Following Third Molar Removal
The purpose of this study is to evaluate the safety and efficacy of LY4515100 and see how a single oral dose compares with placebo in acute postsurgical pain after removing impacted third molars. For each participant, the study may last approximately 6 weeks and will include a stay in a Clinical Research Unit (CRU) after third molar removal.
Participant has a body mass index (BMI) between 18.5 and 35.0 kilograms per mete... [+1]
Prior dental surgery within 60 days before screening or history of other surgica... [+4]